These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11933064)

  • 21. Real-time monitoring of disintegration activity of catalytic core domain of HIV-1 integrase using molecular beacon.
    Zhang DW; Zhao MM; He HQ; Guo SX
    Anal Biochem; 2013 Sep; 440(2):120-2. PubMed ID: 23747532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical interactions between HIV-1 integrase and reverse transcriptase.
    Chakraborty A; Sun GQ; Mustavich L; Huang SH; Li BL
    FEBS Lett; 2013 Mar; 587(5):425-9. PubMed ID: 23270839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexes of HIV-1 integrase with HAT proteins: multiscale models, dynamics, and hypotheses on allosteric sites of inhibition.
    Di Fenza A; Rocchia W; Tozzini V
    Proteins; 2009 Sep; 76(4):946-58. PubMed ID: 19306343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.
    Gao K; Butler SL; Bushman F
    EMBO J; 2001 Jul; 20(13):3565-76. PubMed ID: 11432843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic Hexapeptide Mimics of the LEDGF Integrase Recognition Loop in Complex with HIV-1 Integrase.
    Northfield SE; Wielens J; Headey SJ; Williams-Noonan BJ; Mulcair M; Scanlon MJ; Parker MW; Thompson PE; Chalmers DK
    ChemMedChem; 2018 Aug; 13(15):1555-1565. PubMed ID: 29862651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Mg2+ on the binding modes of HIV-1 integrase with thiazolothiazepine inhibitor studied by molecular simulation.
    Wang L
    Comput Biol Med; 2009 Apr; 39(4):355-60. PubMed ID: 19268284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a novel HIV-1 integrase inhibitor from natural compounds through structure based virtual screening and cell imaging.
    Gu WG; Zhang X; Ip DT; Yang LM; Zheng YT; Wan DC
    FEBS Lett; 2014 Sep; 588(18):3461-8. PubMed ID: 25128456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy.
    Deprez E; Tauc P; Leh H; Mouscadet JF; Auclair C; Brochon JC
    Biochemistry; 2000 Aug; 39(31):9275-84. PubMed ID: 10924120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.
    Sippel M; Sotriffer CA
    J Chem Inf Model; 2010 Apr; 50(4):604-14. PubMed ID: 20230013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and function of HIV-1 integrase.
    Chiu TK; Davies DR
    Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance.
    Barreca ML; Lee KW; Chimirri A; Briggs JM
    Biophys J; 2003 Mar; 84(3):1450-63. PubMed ID: 12609852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A central partition of molecular conformational space. I. Basic structures.
    Gabarro-Arpa J
    Comput Biol Chem; 2003 May; 27(2):153-9. PubMed ID: 12821313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fully flexible low-mode docking: application to induced fit in HIV integrase.
    Keserû GM; Kolossváry I
    J Am Chem Soc; 2001 Dec; 123(50):12708-9. PubMed ID: 11741448
    [No Abstract]   [Full Text] [Related]  

  • 34. Protein conformational landscapes: energy minimization and clustering of a long molecular dynamics trajectory.
    Troyer JM; Cohen FE
    Proteins; 1995 Sep; 23(1):97-110. PubMed ID: 8539254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural dynamics of full-length retroviral integrase: a molecular dynamics analysis.
    Balasubramanian S; Rajagopalan M; Ramaswamy A
    J Biomol Struct Dyn; 2012; 29(6):659-70. PubMed ID: 22545997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.
    Deng J; Lee KW; Sanchez T; Cui M; Neamati N; Briggs JM
    J Med Chem; 2005 Mar; 48(5):1496-505. PubMed ID: 15743192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The catalytic mechanism of HIV-1 integrase for DNA 3'-end processing established by QM/MM calculations.
    Ribeiro AJ; Ramos MJ; Fernandes PA
    J Am Chem Soc; 2012 Aug; 134(32):13436-47. PubMed ID: 22793648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling HIV-1 integrase complexes based on their hydrodynamic properties.
    Podtelezhnikov AA; Gao K; Bushman FD; McCammon JA
    Biopolymers; 2003 Jan; 68(1):110-20. PubMed ID: 12579583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
    Greenwald J; Le V; Butler SL; Bushman FD; Choe S
    Biochemistry; 1999 Jul; 38(28):8892-8. PubMed ID: 10413462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase.
    Guenther S; Nair V
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2233-6. PubMed ID: 12127545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.